4.26
6.77%
0.27
アフターアワーズ:
4.34
0.08
+1.88%
前日終値:
$3.99
開ける:
$4.06
24時間の取引高:
489.88K
Relative Volume:
0.45
時価総額:
$208.10M
収益:
-
当期純損益:
$-67.68M
株価収益率:
-2.4624
EPS:
-1.73
ネットキャッシュフロー:
$-54.24M
1週間 パフォーマンス:
-9.36%
1か月 パフォーマンス:
-26.04%
6か月 パフォーマンス:
-75.16%
1年 パフォーマンス:
-71.02%
Cabaletta Bio Inc Stock (CABA) Company Profile
Cabaletta Bio Inc Stock (CABA) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2023-09-05 | 開始されました | Citigroup | Buy |
2023-07-18 | 開始されました | Guggenheim | Buy |
2023-01-27 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2022-08-30 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2021-12-08 | 開始されました | Wells Fargo | Overweight |
2021-10-19 | 再開されました | Morgan Stanley | Overweight |
2021-06-30 | 開始されました | Mizuho | Buy |
2021-01-08 | 開始されました | Chardan Capital Markets | Buy |
2020-10-13 | 開始されました | H.C. Wainwright | Buy |
2019-11-19 | 開始されました | Cowen | Outperform |
2019-11-19 | 開始されました | Evercore ISI | Outperform |
2019-11-19 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Cabaletta Bio Inc (CABA) 最新ニュース
Lynx1 Capital Management LP Lowers Stock Position in Cabaletta Bio, Inc. (NASDAQ:CABA) - MarketBeat
Cabaletta Bio to Present Key Findings on CABA-201 at ACR Convergence 2024 - MSN
Cabaletta Bio to Present Key Findings on CABA-201 at ACR Convergence 2024 - MyChesCo
Cabaletta Bio to Present New and Updated Clinical Data on CABA-201 in Oral and Poster Presentations at ACR Convergence 2024 - ForexTV.com
Fred Alger Management LLC Sells 587,432 Shares of Cabaletta Bio, Inc. (NASDAQ:CABA) - MarketBeat
Cabaletta Bio to Present New and Updated Clinical Data on CABA-201 in Oral and Poster Presentations at ACR - EIN News
Cabaletta Bio Inc (CABA) Performance and Fundamentals Dashboard tells a completely different story - SETE News
Cabaletta Bio Inc Inc. (CABA) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle
Balance Sheet Breakdown: Cabaletta Bio Inc (CABA)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Technical analysis of Cabaletta Bio Inc (CABA) stock chart patterns - US Post News
Nothing is Better Than Cabaletta Bio Inc (CABA) stock at the moment - SETE News
Cabaletta Bio Inc: Navigating Market Fluctuations with a 204.68M Market Cap - The InvestChronicle
Cabaletta Bio, Inc. (NASDAQ:CABA) Shares Purchased by E Fund Management Co. Ltd. - MarketBeat
Cabaletta Bio shares maintain Buy rating from H.C. Wainwright - Investing.com India
Cabaletta Bio (NASDAQ:CABA) Stock Rating Reaffirmed by HC Wainwright - MarketBeat
Cabaletta Bio shares maintain Buy rating from H.C. Wainwright By Investing.com - Investing.com UK
Financial Fitness Check: Examining Cabaletta Bio Inc (CABA)’s Key Ratios - The Dwinnex
Was anything positive for Cabaletta Bio Inc (CABA) stock last session? - US Post News
Cabaletta Bio, Inc. (NASDAQ:CABA) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
TD Asset Management Inc Raises Holdings in Cabaletta Bio, Inc. (NASDAQ:CABA) - Defense World
Cabaletta Bio, Inc. (NASDAQ:CABA) Given Average Rating of “Buy” by Analysts - Defense World
Cabaletta Bio Inc (CABA) Stock: Navigating Drops and Gains - The InvestChronicle
Is it possible to buy Cabaletta Bio Inc(CABA) shares at a good price now? - US Post News
Metric Analysis: Cabaletta Bio Inc (CABA)’s Key Ratios in the Limelight - The Dwinnex
Several Headwinds Dragged Cabaletta Bio (CABA) in Q2 - MSN
Reviewing LadRx (OTCMKTS:CYTR) & Cabaletta Bio (NASDAQ:CABA) - Defense World
CABA Stock: A Comprehensive Analysis and Forecast - The InvestChronicle
We're Hopeful That Cabaletta Bio (NASDAQ:CABA) Will Use Its Cash Wisely - Simply Wall St
Ratios Uncovered: Breaking Down Cabaletta Bio Inc (CABA)’s Trailing Twelve Months Metrics - The Dwinnex
Is Cabaletta Bio Inc (CABA) worth investing in despite its undervalued state? - US Post News
Cabaletta Bio, Inc. (NASDAQ:CABA) Sees Significant Drop in Short Interest - MarketBeat
299,801 Shares in Cabaletta Bio, Inc. (NASDAQ:CABA) Bought by Panagora Asset Management Inc. - MarketBeat
Passage Bio CEO to Present at H.C. Wainwright Global Investment Conference - MyChesCo
Cabaletta Bio, Inc. Set to Engage at Key Investor Conferences - MSN
Financial Health Report: Cabaletta Bio Inc (CABA)’s Ratios Tell a Tale - The Dwinnex
Cabaletta Bio, Inc. Set to Engage at Key Investor Conferences - MyChesCo
Cabaletta Bio to Participate in Upcoming Investor Conferences in September - ForexTV.com
Cabaletta Bio to Participate in Upcoming Investor Conferences in September - GlobeNewswire Inc.
There is no doubt that Cabaletta Bio Inc (CABA) ticks all the boxes. - SETE News
Cabaletta Bio Inc (CABA) stock analysis: A simple moving average approach - US Post News
CABA’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Cabaletta Bio Welcomes Sarah Yuan, PhD, as New Chief Technology Officer - BioBuzz
Financial Analysis: Cabaletta Bio Inc (CABA)’s Ratios Unveil Key Insights - The Dwinnex
Holdings of Cabaletta Bio Inc (CABA) are aligned with the stars - SETE News
Cabaletta Bio, Inc. (NASDAQ:CABA) Given Average Rating of “Buy” by Brokerages - Defense World
Several Headwinds Dragged Cabaletta Bio (CABA) in Q2 - Insider Monkey
Several Headwinds Dragged Cabaletta Bio (CABA) in Q2 - Yahoo Finance
Cabaletta Bio, Inc. (NASDAQ:CABA) Receives $30.11 Consensus Price Target from Analysts - MarketBeat
Investing in Cabaletta Bio Inc (CABA) might be a great opportunity, but the stock is a bit overvalued - US Post News
Cabaletta Bio, Inc. (NASDAQ:CABA) Sees Significant Increase in Short Interest - MarketBeat
Stifel sees Cabaletta Bio stock poised for recovery despite recent volatility - Investing.com
Cabaletta Bio Inc (CABA) 財務データ
収益
当期純利益
現金流量
EPS
Cabaletta Bio Inc (CABA) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Binder Gwendolyn | See Remarks |
Jan 19 '24 |
Sale |
19.59 |
11,000 |
215,439 |
20,000 |
Binder Gwendolyn | See Remarks |
Dec 19 '23 |
Option Exercise |
1.01 |
11,000 |
11,110 |
31,000 |
Binder Gwendolyn | See Remarks |
Dec 19 '23 |
Sale |
21.89 |
11,000 |
240,789 |
20,000 |
Binder Gwendolyn | See Remarks |
Nov 20 '23 |
Option Exercise |
1.01 |
11,000 |
11,110 |
31,000 |
Binder Gwendolyn | See Remarks |
Nov 20 '23 |
Sale |
17.82 |
11,000 |
196,014 |
20,000 |
Binder Gwendolyn | See Remarks |
Oct 19 '23 |
Option Exercise |
1.01 |
11,000 |
11,110 |
31,000 |
Binder Gwendolyn | See Remarks |
Oct 19 '23 |
Sale |
13.36 |
11,000 |
146,921 |
20,000 |
大文字化:
|
ボリューム (24 時間):